Deep Learning Pipeline for Accelerating Virtual Screening in Drug Discovery

Area of Science:

• * Computational chemistry and cheminformatics.
• * Artificial intelligence and machine learning.
• * Pharmaceutical sciences and drug discovery.

Background:

• * Traditional virtual screening methods face challenges like computational inefficiency, poor generalization, and reliance on predefined descriptors.
• * Deep learning (DL) offers advanced solutions to these limitations in drug discovery.
• * DL models can enhance hit identification, lead optimization, and molecular property prediction.

Purpose of the Study:

• * To explore the systematic deep learning pipeline for virtual screening in drug discovery.
• * To discuss advanced model optimization techniques and emerging trends in AI-driven drug discovery.
• * To highlight how AI-powered virtual screening accelerates therapeutic development.

Main Methods:

• * Utilizing graph neural networks (GNNs), transformer-based models, generative AI, and reinforcement learning.
• * Implementing a systematic DL pipeline: data acquisition, molecular representation learning, model architectures, training strategies, and uncertainty estimation.
• * Applying advanced optimization techniques: curriculum learning, transfer learning, and adversarial training.

Main Results:

• * Deep learning significantly improves virtual screening efficiency and accuracy compared to traditional methods.
• * Advanced DL techniques enhance predictive accuracy and robustness for drug candidate discovery.
• * AI-powered virtual screening accelerates early-stage drug discovery, reducing costs and improving efficiency.

Conclusions:

• * Deep learning revolutionizes virtual screening, offering powerful tools for identifying novel drug candidates.
• * Challenges in data quality, interpretability, and generalization persist but are being addressed by emerging trends.
• * Integration of AI with experimental validation is crucial for the next generation of drug discovery.